Protection of mice against SV40 tumours by Pam 3 Cys, MTP-PE and Pam 3 Cys conjugated with the SV40 T antigen-derived peptide, K(698)-T(708)

Author： Obert M.   Pleuger H.   Hanagarth H.-G.   Schulte-Monting J.   Wiesmuller K.-H.   Braun D.G.   Brandner G.   Hess R.D.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.16, Iss.2, 1998-01, pp. : 161-169

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immune responses against SIV envelope glycoprotein, using recombinant SV40 as a vaccine delivery vector

By McKee H.J.   Strayer D.S.  

Vaccine, Vol. 20, Iss. 29, 2002-10 ,pp. : 3613-3625

Elsevier

Access to resources Recommend Favorite

Detection and growth kinetics of SV40 preparations with different enhancer element copy number

By Minor P.D.   Dunn G.   Pipkin P.A.  

Vaccine, Vol. 19, Iss. 25, 2001-05 ,pp. : 3467-3471

Elsevier

Access to resources Recommend Favorite

Protection of mice against lethal viral infection by synthetic peptides corresponding to B- and T-cell recognition sites of influenza A hemagglutinin

By Simeckova-Rosenberg J.   Zhong Y.   Wyde P.R.   Atassi M.Z.  

Vaccine, Vol. 13, Iss. 10, 1995-07 ,pp. : 927-932

Elsevier

Access to resources Recommend Favorite

Long-term protection of mice against Leishmania major with a synthetic peptide vaccine

By Spitzer N.   Jardim A.   Lippert D.   Olafson R.W.  

Vaccine, Vol. 17, Iss. 11, 1999-03 ,pp. : 1298-1300

Elsevier

Access to resources Recommend Favorite

Antibody and cytotoxic T-lymphocyte responses to a single liposome-associated peptide antigen

By White W.I.   Cassatt D.R.   Madsen J.   Burke S.J.   Woods R.M.   Wassef N.M.   Alving C.R.   Koenig S.  

Vaccine, Vol. 13, Iss. 12, 1995-08 ,pp. : 1111-1122

Elsevier

Access to resources Recommend Favorite